Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Cancer Drug Targets|March 6, 2010
Inhibitors of HDACs--effective drugs against cancer?S Müller, O H KrämerTrends in Endocrinology and Metabolism: TEM|August 16, 2001
Histone deacetylase as a therapeutic targetO H Krämer, M Göttlicher, T HeinzelOncogene|July 27, 2007
Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosisO H Krämer, S K Knauer, D Zimmermann, et al.Leukemia|October 6, 2012
SIAH proteins: critical roles in leukemogenesisO H Krämer, R H Stauber, G Bug, et al.Leukemia|May 29, 2010
Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradationM Buchwald, K Pietschmann, J P Müller, et al.Oncogene|December 5, 2012
SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradationM Buchwald, K Pietschmann, P Brand, et al.British Journal of Cancer|November 28, 2013
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitorsJ Sonnemann, C Marx, S Becker, et al.British Journal of Cancer|December 17, 2014
Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cellsD Hennig, S Müller, C Wichmann, et al.The EMBO Journal|December 18, 2001
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cellsM Göttlicher, S Minucci, P Zhu, et al.Oncogene|March 2, 2010
Cross talk between stimulated NF-kappaB and the tumor suppressor p53G Schneider, A Henrich, G Greiner, et al.Pageof 2